FC
ALXN

Fiera Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Fiera Capital’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$1.16M Sell
10,000
-8,000
-44% -$878K 0.08% 77
2013
Q2 		$1.66M Buy
+18,000
New +$1.73M 0.12% 66

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fiera Capital's ALXN Position: Q3 2013 in Review

Fiera Capital reduced its Alexion Pharmaceuticals (ALXN) stake by 44% in Q3 2013, selling an estimated $878K and leaving 10,000 shares worth $1.16M. The position accounts for 0.08% of the portfolio, ranked #77.

Fiera Capital first reported a position in ALXN in Q2 2013 and has held it in 2 quarters since. The position peaked at $1.66M in Q2 2013. 437 funds tracked by Wall St. Rank hold ALXN as of Q3 2013.

  • Fiera Capital held 10,000 shares of Alexion Pharmaceuticals worth $1.16M as of Q3 2013.
  • Fiera Capital sold 8,000 Alexion Pharmaceuticals shares in Q3 2013, an estimated $878K.
  • Alexion Pharmaceuticals made up 0.08% of Fiera Capital's portfolio in Q3 2013, its #77 holding.
  • Fiera Capital first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 2 quarters since.
  • Fiera Capital's Alexion Pharmaceuticals position peaked at $1.66M in Q2 2013.
  • 437 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2013.

Based on Fiera Capital's 13F filing for Q3 2013, filed 14 Nov 2013.